EGFR variant allele frequency predicts EGFR-TKI efficacy in lung adenocarcinoma: a multicenter study

BACKGROUND: Although lung adenocarcinoma (LADC) with sensitizing mutations of the epidermal growth factor receptor (EGFR) is highly sensitive to EGFR tyrosine kinase inhibitors (EGFR-TKIs), in most cases disease progression inevitably occurs. Our aim was to investigate the predictive and prognostic...

Descripción completa

Detalles Bibliográficos
Autores principales: Gieszer, Balazs, Megyesfalvi, Zsolt, Dulai, Viktoria, Papay, Judit, Kovalszky, Ilona, Timar, Jozsef, Fillinger, Janos, Harko, Tunde, Pipek, Orsolya, Teglasi, Vanda, Regos, Eszter, Papp, Gergo, Szallasi, Zoltan, Laszlo, Viktoria, Renyi-Vamos, Ferenc, Galffy, Gabriella, Bodor, Csaba, Dome, Balazs, Moldvay, Judit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947383/
https://www.ncbi.nlm.nih.gov/pubmed/33718012
http://dx.doi.org/10.21037/tlcr-20-814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947383/
https://www.ncbi.nlm.nih.gov/pubmed/33718012
http://dx.doi.org/10.21037/tlcr-20-814

Ejemplares similares